|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income (Loss) Attributable to Parent | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Amortization of debt discount | |||||
| Stock-based compensation | |||||
| Amortization of deferred financing costs | |||||
| Loss on debt extinguishment | |||||
| Goodwill impairment | |||||
| Loss on modification of revolver | |||||
| Provision for credit losses | |||||
| Impairment of software asset | |||||
| Provision for inventory reserves | |||||
| Loss on change in fair value of contingent consideration | |||||
| Gain on settlement of contingent consideration | |||||
| Deferred income taxes | |||||
| Gain on change in fair value of warrants | |||||
| Change in fair value of warrant | |||||
| Warrants in Debt and Equity Offerings to Finance Merger | |||||
| Loss on warrant amendment | |||||
| Loss on settlement of obligations | |||||
| Total loss on settlement of obligations | |||||
| Changes to operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Increase (Decrease) in Accrued Liabilities | |||||
| Deferred revenue | |||||
| Customer deposits | |||||
| Other, net | |||||
| Other assets | |||||
| Lease liabilities | |||||
| Other non-current liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Investing Activities: | |||||
| Cash paid for acquisition of Cineplex Digital Media (net of cash acquired) | |||||
| Purchases of property and equipment | |||||
| Capitalization of costs for software development | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Proceeds from sale of common stock, net of offering expenses | |||||
| Proceeds from Term Loan | |||||
| Acquisition Term Loan | |||||
| Term Loan 2022 | |||||
| Proceeds from sale & exercise of pre-funded warrants in PIPE, net of offering expenses | |||||
| Proceeds from sale of common stock in PIPE, net of offering expenses | |||||
| Proceeds from sale of Series A Redeemable Convertible Preferred Stock | |||||
| Payment of issuance costs related to Series A Redeemable Convertible Preferred Stock | |||||
| Proceeds from term debt | |||||
| Repayment of term debts | |||||
| Term Loan 2022 | |||||
| Consolidated Term Loan | |||||
| Secured Promissory Note | |||||
| Total repayment of term debts | |||||
| Proceeds from borrowings under revolving credit facility | |||||
| Repayment of borrowings under revolving credit facility | |||||
| Payment of contingent consideration | |||||
| Payment of deferred financing costs | |||||
| Repayment of finance lease obligations | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Effect of exchange rate on cash and cash equivalents | |||||
Loading...